SOLVENTUM CORPORATION Revenue
SOLVENTUM CORPORATION (SOLV) reported Revenue of $2.21 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-05
- SOLVENTUM CORPORATION revenues for the quarter ending 2026-06-30 was $2.21B, a 2.22% increase year-over-year.
- SOLVENTUM CORPORATION revenues for the quarter ending 2026-03-31 was $2.01B, a 3.04% decline year-over-year.
- SOLVENTUM CORPORATION revenues for the quarter ending 2025-12-31 was $2.00B, a 3.71% decline year-over-year.
- SOLVENTUM CORPORATION revenues for the quarter ending 2025-09-30 was $2.10B, a 0.67% increase year-over-year.
- SOLVENTUM CORPORATION revenues for fiscal 2025 was $8.32B, a 0.86% increase from fiscal 2024.
- SOLVENTUM CORPORATION revenues for fiscal 2024 was $8.25B, a 0.70% increase from fiscal 2023.
- SOLVENTUM CORPORATION revenues for fiscal 2023 was $8.20B, a 0.82% increase from fiscal 2022.
- SOLVENTUM CORPORATION revenues for fiscal 2022 was $8.13B.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.21B 10-Q · filed 2026-08-05 | $4.22B 10-Q · filed 2026-08-05 | $6.21B derived: sum of 3 quarters · filed 2026-08-05 | $8.31B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.01B 10-Q · filed 2026-05-05 | $4.00B derived: sum of 2 quarters · filed 2026-05-05 | $6.10B derived: sum of 3 quarters · filed 2026-05-05 | $8.26B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.00B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.09B derived: sum of 2 quarters · filed 2026-02-27 | $6.25B derived: sum of 3 quarters · filed 2026-08-05 | $8.32B 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.10B 10-Q · filed 2025-11-06 | $4.26B derived: sum of 2 quarters · filed 2026-08-05 | $6.33B 10-Q · filed 2025-11-06 | $8.40B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.16B 10-Q · filed 2026-08-05 | $4.23B 10-Q · filed 2026-08-05 | $6.31B derived: sum of 3 quarters · filed 2026-08-05 | $8.39B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.07B 10-Q · filed 2026-05-05 | $4.14B derived: sum of 2 quarters · filed 2026-05-05 | $6.23B derived: sum of 3 quarters · filed 2026-05-05 | $8.31B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $2.08B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.16B derived: sum of 2 quarters · filed 2026-02-27 | $6.24B derived: sum of 3 quarters · filed 2026-02-27 | $8.25B 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.08B 10-Q · filed 2025-11-06 | $4.16B derived: sum of 2 quarters · filed 2025-11-06 | $6.18B 10-Q · filed 2025-11-06 | $8.21B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $2.08B 10-Q · filed 2025-08-08 | $4.10B 10-Q · filed 2025-08-08 | $6.13B derived: sum of 3 quarters · filed 2026-02-27 | $8.21B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $2.02B 10-Q · filed 2025-05-09 | $4.05B derived: sum of 2 quarters · filed 2026-02-27 | $6.13B derived: sum of 3 quarters · filed 2026-02-27 | $8.20B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.04B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.11B derived: sum of 2 quarters · filed 2026-02-27 | $6.19B derived: sum of 3 quarters · filed 2026-02-27 | $8.20B 10-K · filed 2026-02-27 |
| 2023-09-30 | $2.07B 10-Q · filed 2024-11-08 | $4.15B derived: sum of 2 quarters · filed 2024-11-08 | $6.16B 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $2.08B 10-Q · filed 2024-08-09 | $4.09B 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $2.01B 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $8.13B 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |